Table 1.
Patient characteristics are presented as absolute number n and percentage or median and interquartile range.
| Patient Characteristics | LT Recipients n/(%) |
HCWs n/(%) |
p-Value |
|---|---|---|---|
| Total patient number | 43 | 20 | - |
| Sex (male/female) | 26(60.5)/17 (39.5) | 9 (45)/11 (55) | 0.286 |
| SARS-CoV-2 IgG detectability rate | 34 (79) | 20 (100) | 0.047 |
| Median (IQR) | Median (IQR) | ||
| Age of recipient at LT [years] | 47 (36–54) | - | - |
| Time between LT and first dose [years] | 8 (4–12) | - | - |
| Age at first dose [years] | 57 (49–64) | 43.5 (38–53.5) | 0.002 |
| Time between first and second doses [days] | 26 (21–37) | 22 | 0.448 |
| Time between second dose and SARS-CoV-2 Ab detection [days] | 15 (12–24) | 13 | 0.033 |
| SARS-CoV-2 IgG (BAU/mL) | 216 (43.4–1090) | >2080 (1865.5 to >2080) | 0.0001 |
LT: liver transplantation; HCWs: healthcare workers; Ab: antibody; BAU: binding antibody units; IQR: interquartile range.